Watson Pharmaceuticals, established in 1985, specialized in the development, manufacturing, and marketing of generic and branded medicines. Key therapeutic areas included women's health, nephrology, and general medicine. In 2012, Watson rebranded as Actavis, a significant step in its evolution. Actavis merged with Allergan in 2015, forming Allergan plc, which continues Watson's legacy by contributing to innovative healthcare solutions. This transition highlights Watson's impact on the pharmaceutical industry.

Logo out of use